2010
Human Papillomavirus for Cervical Pathology
Chhieng D, Hui P. Human Papillomavirus for Cervical Pathology. Current Clinical Pathology 2010, 81-85. DOI: 10.1007/978-1-60761-164-6_5.Peer-Reviewed Original ResearchHuman papillomavirusLow-risk HPV subtypesAnogenital human papillomavirusLow-risk groupGenital human papillomavirusHuman cervical cancerHigh-risk genital human papillomavirusesBenign skin papillomasSpecific tissue sitesHPV subtypesHPV 6Cervical cancerHPV 16Gynecological cancerRisk groupsCervical pathologySkin papillomasProliferative disordersHPV-1Tissue sitesPapillomavirusCancerCondylomaAdenocarcinomaGroup
2008
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proceedings Of The National Academy Of Sciences Of The United States Of America 2008, 105: 652-656. PMID: 18178624, PMCID: PMC2206591, DOI: 10.1073/pnas.0708594105.Peer-Reviewed Original ResearchConceptsCancer immunoeditingWT controlsAdaptor myeloid differentiation factor 88Myeloid differentiation factor 88Adaptive immune surveillanceMyD88-/- miceMyD88-deficient miceRole of TNFDMBA/TPAInflammation-induced cancerDistinct mouse modelsTNF-deficient miceInflammation-induced carcinogenesisO-tetradecanoylphorbol 13Mouse tumor modelsFactor 88WT miceChronic inflammationMCA sarcomaProinflammatory processesTumor immunologistsImmune surveillanceMouse modelSkin papillomasPrimary tumorigenesis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply